Camptothecin induces p53-dependent and -independent apoptogenic signaling in melanoma cells

E Rudolf1, K Rudolf, M Cervinka

  • 1Department of Medical Biology and Genetics, Charles University in Prague, Faculty of Medicine in Hradec Králové, Šimkova 870, 500 38 Hradec Králové, Czech Republic. rudolf@lfhk.cuni.cz

Insights

Camptothecin triggers apoptosis in melanoma cells through p53-dependent and independent pathways. Understanding these mechanisms, including p73 and caspase-2, is crucial for developing effective melanoma treatments.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cellular Biology

Background:

  • DNA-targeting agents can induce apoptosis via p53-dependent and independent pathways.
  • The interplay of molecules like p73, caspase-2, and Bcl-2 family proteins in apoptosis is not fully understood, especially in malignant melanoma.
  • Malignant melanoma is a highly aggressive cancer with complex apoptotic signaling.

Purpose of the Study:

  • To investigate the roles of p53-dependent and independent mechanisms in melanoma apoptosis.
  • To elucidate the involvement of p73 and caspase-2 in camptothecin-induced apoptosis in melanoma cells with different p53 statuses.
  • To explore the impact of p53 status on microRNA expression and apoptosis in response to camptothecin.

Main Methods:

  • Utilized camptothecin (CPT), a DNA topoisomerase I inhibitor, on selected melanoma cell lines with varying p53 status.
  • Assessed apoptosis induction, p53-dependent and independent signaling pathways, and microRNA expression (miR-34, miR-155).
  • Investigated the effect of ectopic wild-type p53 expression on apoptotic response to CPT.

Main Results:

  • Camptothecin induced significant apoptosis in wild-type p53 Bowes melanoma cells, dependent on p53 and mitochondria, with involvement of caspase-2 and p73.
  • In mutant p53 melanoma cells, CPT-induced apoptosis was lower, with p73 and caspase-2 signaling playing key roles.
  • Mutant p53 cells showed lower miR-34 expression; ectopic wild-type p53 restored apoptosis but did not influence miR-34 or miR-155 levels.

Conclusions:

  • Camptothecin triggers multifaceted cellular stress responses in melanoma, involving both p53-dependent DNA damage response and p53-independent signaling.
  • The crosstalk between these pathways is critical for efficient apoptosis induction in melanoma cells.
  • Targeting these complex apoptotic mechanisms may offer therapeutic strategies for malignant melanoma.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...